Scientists test new radiation drug for Tough-to-Treat prostate cancer
NCT ID NCT03042468
Summary
This study is testing different doses of an experimental drug called 177Lu-PSMA-617 in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The main goal is to find the highest dose that can be given safely without causing severe side effects. Researchers will also check if the treatment helps control the cancer by measuring PSA levels and tumor scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tulane Cancer Center Clinic
New Orleans, Louisiana, 70112, United States
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.